Badger Meter (BMI) Q2 2026 Earnings Call Transcript

Badger Meter reported Q2 total sales of $222.3M, down 7% YoY, with diluted EPS of $1.02 down 13% YoY as operating margin fell 110 bps to 17.7% and free cash flow declined to $21.9M from $40.6M. Management reaffirmed full-year 2026 organic revenue guidance as “flattish” vs 2025 (sequential improvement expected, with YoY growth weighted to Q4) while citing project pacing and ongoing electronics component cost/availability pressures. The company repurchased 204k shares for $25.3M in Q2 and has ~$90M remaining under its authorization, alongside a renewed $150M undrawn credit facility.

Analysis

The market should treat this as a timing problem, not a demand reset. The important implication is that earnings quality is still high enough to support the multiple, but cash conversion and inventory normalization can lag by a quarter or two when large municipal deployments start/stall, so the stock may remain range-bound until investors see consecutive quarters of sequential revenue acceleration.

The bigger second-order issue is supply-chain leverage: AI-driven electronics scarcity is a tax on the whole smart-meter ecosystem, but scale players with pricing power and platform flexibility should emerge better positioned than smaller AMI vendors. That makes BMI relatively stronger versus more fragmented metering peers, while also creating a hidden tailwind from data-center instrumentation demand that is real but not large enough to offset project lumpiness on its own.

Contrarian view: consensus may be over-focusing on the soft top line and underestimating how much of the year’s setup is pushed into Q4. The more relevant falsifier is not one bad quarter; it is a failure of sequential growth to persist into Q3/Q4, a gross margin slip below the low-40s floor, or working capital failing to unwind as shipments ramp. If those do not improve, the stock stops looking like a compounder and starts trading like a cyclically delayed project business.

Key Decisions for Investors

• Tactical long BMI on post-earnings weakness over the next 1-3 weeks; target the Q4 acceleration catalyst, but only if the stock sells off on timing concerns rather than a guide cut.
• Use Q3 results as the key check: if BMI does not post sequential revenue growth and management does not reaffirm a Q4-weighted profile, reduce or exit the long.
• Relative-value long BMI / short ITRI for 1-3 months: BMI has better balance-sheet flexibility and a more visible multi-quarter project ramp, while both names face similar electronics/input-cost pressure.
• Do not chase the name after a relief rally; wait for a reset to a lower multiple after the market digests weaker quarterly optics.
• Watch item, not recommendation: if electronics cost pressure persists into the next quarter without margin recovery, re-underwrite to a lower operating-margin band and de-risk the position.